| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |